Atlas Trials

A Trial of Remdesivir in Adults With Severe COVID-19

Clinical trial NCT04257656 · TERMINATED

Trial details

NCT number
NCT04257656
Sponsor
Capital Medical University
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
COVID-19RemdesivirSARS-CoV-2
Start date
2020-02-06
Primary completion
2020-03-30
Enrollment
237

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.